These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 231852)

  • 1. Search for antibodies to LH receptors in serum of women with polycystic ovarian disease.
    Bolton RA; Coulam CB; Ryan RJ
    Surg Forum; 1979; 30():464-6. PubMed ID: 231852
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection.
    Shterev AD; Dokumov SI
    Endocrinologie; 1982; 20(3):203-7. PubMed ID: 6815773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome. An autoimmune disease?
    Rojansky N; Roll D; Meirow D
    J Reprod Med; 1997 Jun; 42(6):325-8. PubMed ID: 9219117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
    Milsom SR; Sowter MC; Carter MA; Knox BS; Gunn AJ
    BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of antiovarian antibodies after laparoscopic ovarian electrocauterization in patients with polycystic ovary syndrome.
    Alborzi S; Tavazoo F; Dehaghani AS; Ghaderi A; Alborzi S; Alborzi M
    Fertil Steril; 2009 Apr; 91(4):1159-63. PubMed ID: 18439597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin.
    Meyer WR; Lavy G; DeCherney AH; Visintin I; Economy K; Luborsky JL
    Obstet Gynecol; 1990 May; 75(5):795-9. PubMed ID: 2109293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion.
    Ushiroyama T; Ikeda A; Sakai M; Hosotani T; Suzuki Y; Tsubokura S; Ueki M
    J Reprod Med; 2001 May; 46(5):451-6. PubMed ID: 11396371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anovulation with estrogen production: receptor disorders?
    Bolton RA; Coulam CB; Ryan RJ
    Obstet Gynecol; 1980 Sep; 56(3):344-8. PubMed ID: 6252524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases.
    van Gelderen CJ; Gomes dos Santos ML
    J Reprod Med; 1993 May; 38(5):381-6. PubMed ID: 8320676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative luteinizing hormone levels predict the ovulatory response to laparoscopic ovarian drilling in patients with clomiphene citrate-resistant polycystic ovary syndrome.
    Hayashi H; Ezaki K; Endo H; Urashima M
    Gynecol Endocrinol; 2005 Dec; 21(6):307-11. PubMed ID: 16390777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ovarian drilling in middle Black Sea region Turkish women with polycystic ovary syndrome having normal and high body mass indices.
    Demirturk F; Caliskan AC; Aytan H; Erkorkmaz U
    J Obstet Gynaecol Res; 2006 Oct; 32(5):507-12. PubMed ID: 16984519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients.
    Moret M; Stettler R; Rodieux F; Gaillard RC; Waeber G; Wirthner D; Giusti V; Tappy L; Pralong FP
    Neuroendocrinology; 2009; 89(2):131-9. PubMed ID: 18832802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing hormone, adrenal androgenesis, and polycystic ovarian disease.
    Polansky S
    Obstet Gynecol; 1975 Apr; 45(4):451-4. PubMed ID: 1121374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome in autoimmune disease.
    Fénichel P; Gobert B; Carré Y; Barbarino-Monnier P; Hiéronimus S
    Lancet; 1999 Jun; 353(9171):2210. PubMed ID: 10392989
    [No Abstract]   [Full Text] [Related]  

  • 19. Posterior pituitary extract and luteinising hormone antibodies.
    Hughes IA; Ward ID; Goldie DJ
    Lancet; 1982 Jan; 1(8263):115. PubMed ID: 6119488
    [No Abstract]   [Full Text] [Related]  

  • 20. [A rapid method of determining anti-thyrotropin-receptor antibodies].
    Izembart M; de Cremoux P; Di Gioia Y; Vallee G
    Presse Med; 1984 Jul 14-21; 13(29):1787-8. PubMed ID: 6087311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.